당뇨망막병증 및 당뇨황반부종환자에서의 중증도에 따른 전방수내 사이토카인 상관관계 분석

키워드

참고문헌 (35)

1. Murugeswari P, "Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ disease", Retina, 28, pp.817~824 (2008)
2. Funatsu H, "Increased levels of vascular enthothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema", Am J Ophthalmol, 133, pp.70~77 (2002)
3. Aiello LP, "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", N Engl J Med, 331, pp.1480~1487 (1994)
4. Boyd SR, "Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion", Arch Ophthalmol, 120, pp.1644~1650 (2002)
5. Moss SE, "Ten-year incidence of visual loss in a diabetic population", Ophthalmology, 101, pp.1061~1070 (1994)
6. Moss SE, "The 14-year incidence of visual loss in diabetic population", Ophthalmology, 105, pp.998~1003 (1998)
7. Funatsu H, "Vitreous levels of interleukin- 6 and vascular endothelial growth factor are related to diabetic macular edema", Ophthalmology, 110, pp.1690~1696 (2003)
8. Funatsu H, "Association of vitreous inflammatory factors with diabetic macular edema", Ophthalmology, 116, pp.73~79 (2009)
9. Joussen AM, "A central role for inflammation in the pathogenesis of diabetic retinopathy", FASEB J, 18, pp.1450~1452 (2004)
10. Paccola L, "Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular edema(IBEME study)", Br J Ophthalmol, 92, pp.76~80 (2008)
11. Early treatment Diabetic Retinopathy Study Research group, "Grading diabetic retinopathy from stereoscopic color fundus photographs- An extension of the modified Airlie House classification. ETDRS report number 10", Ophthalmology, 98, pp.786~806 (1991)
12. Fisman EZ, "Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof", Cardiovasc Diabetol, 2, pp.11~ (2003)
13. Elshal MF, "Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA", Methods, 38, pp.317~323 (2006)
14. Dupont NC, "Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants", J Reprod Immunol, 66, pp.175~191 (2005)
15. Goldberg RB, "Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications", J Clin Endocrinol Metab, 94, pp.3171~3182 (2009)
16. Gustavsson C, "Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy", Acta Ophthalmol (2012)
17. Hoekzema R, "Analysis of interleukin- 6 in endotoxin-induced uveitis", Invest Ophthalmol Vis Sci, 32, pp.88~95 (1991)
18. Hernandez C, "Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy", Diabet Med, 22, pp.719~722 (2005)
19. Kim KS, "A novel role of hypoxia- inducible factor in cobalt chloride- and hypoxiamediated expression of IL-8 chemokine in human endothelial cells", J Immunol, 177, pp.7211~7224 (2006)
20. Schober A, "Chemokines in vascular remodeling", Thromb Haemost, 97, pp.730~737 (2007)
21. Tashimo A, "Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein- 1 in patients with diabetic retinopathy", Diabet Med, 21, pp.1292~1297 (2004)
22. Myśliwiec M, "The activity of N-acetyl- beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children", Clin Biochem, 39, pp.851~856 (2006)
23. Silvestre JS, "Antiangiogenic effect of interleukin- 10 in ischemia-induced angiogenesis in mice hindlimb", Circ Res, 87, pp.448~452 (2000)
24. Cheung CM, "Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy", Mol Vis, 18, pp.830~837 (2012)
25. Ozturk BT, "Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness", Mol Vis, 15, pp.1906~1914 (2009)
26. Rangasamy S, "Diabetic retinopathy and inflammation: novel therapeutic targets", Middle East Afr J Ophthalmol, 19, pp.52~59 (2012)
27. Hershey GK., "IL-13 receptors and signaling pathways: an evolving web", J Allergy Clin Immunol, 111, pp.677~690 (2003)
28. Chen H, "Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy", Mol Vis, 18, pp.219~226 (2012)
29. Hanifi-Moghaddam P, "Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus", Diabet Med, 23, pp.156~163 (2006)
30. Roberge FG, "Treatment of uveitis with recombinant human interleukin-13", Br J Ophthalmol, 82, pp.1195~1198 (1998)
31. Haas CS, "In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis", Arthritis Rheum, 56, pp.2535~2548 (2007)
32. Fisman EZ, "Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof", Cardiovasc Diabetol, 2, pp.11~ (2003)
33. Noma H, "Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion", Eye (Lond), 22, pp.42~48 (2008)
34. Funatsu H, "Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients", Graefes Arch Clin Exp Ophthalmol, 243, pp.3~8 (2005)
35. Bakri SJ, "Pharmacokinetics of intravitreal bevacizumab (Avastin)", Ophthalmology, 114, pp.855~859 (2007)

관련 논문AI추천